118 related articles for article (PubMed ID: 1411847)
1. Treatment of chancroid with a single dose of spectinomycin.
Guzmán M; Guzmán J; Bernal M
Sex Transm Dis; 1992; 19(5):291-4. PubMed ID: 1411847
[TBL] [Abstract][Full Text] [Related]
2. Treatment of chancroid with spectinomycin or co-trimoxazole.
Traisupa A; Ariyarit C; Metheeprapha C; Buatiang A; Sungthong P
Clin Ther; 1990; 12(3):200-5. PubMed ID: 2165860
[TBL] [Abstract][Full Text] [Related]
3. A comparative study of spectinomycin and erythromycin in the treatment of chancroid.
Ballard RC; da L'Exposto F; Dangor Y; Fehler HG; Miller SD; Koornhof HJ
J Antimicrob Chemother; 1990 Sep; 26(3):429-34. PubMed ID: 2146242
[TBL] [Abstract][Full Text] [Related]
4. A comparison of single-dose spectinomycin with five days of trimethoprim-sulfamethoxazole for the treatment of chancroid.
Fransen L; Nsanze H; Jo-Ndinya-Achola ; D'Costa L; Ronald AR; Piot P
Sex Transm Dis; 1987; 14(2):98-101. PubMed ID: 2956702
[TBL] [Abstract][Full Text] [Related]
5. Cefotaxime treatment of Haemophilus ducreyi infection in Kenya.
Plummer FA; Maggwa N; D'Costa LJ; Nsanze H; Karasira P; Maclean IW; Ronald AR
Sex Transm Dis; 1984; 11(4):304-7. PubMed ID: 6098034
[TBL] [Abstract][Full Text] [Related]
6. Comparative study of ceftriaxone and trimethoprim-sulfamethoxazole for the treatment of chancroid in Thailand.
Taylor DN; Pitarangsi C; Echeverria P; Panikabutra K; Suvongse C
J Infect Dis; 1985 Nov; 152(5):1002-6. PubMed ID: 3876396
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of 500- and 1,000-mg doses of ciprofloxacin for the treatment of chancroid.
Bodhidatta L; Taylor DN; Chitwarakorn A; Kuvanont K; Echeverria P
Antimicrob Agents Chemother; 1988 May; 32(5):723-5. PubMed ID: 3293526
[TBL] [Abstract][Full Text] [Related]
8. In vitro susceptibilities of isolates of Haemophilus ducreyi from Thailand and the United States to currently recommended and newer agents for treatment of chancroid.
Knapp JS; Back AF; Babst AF; Taylor D; Rice RJ
Antimicrob Agents Chemother; 1993 Jul; 37(7):1552-5. PubMed ID: 8363390
[TBL] [Abstract][Full Text] [Related]
9. Failure of treatment for chancroid in Rwanda is not related to human immunodeficiency virus infection: in vitro resistance of Haemophilus ducreyi to trimethoprim-sulfamethoxazole.
Bogaerts J; Kestens L; Martinez Tello W; Akingeneye J; Mukantabana V; Verhaegen J; Van Dyck E; Piot P
Clin Infect Dis; 1995 Apr; 20(4):924-30. PubMed ID: 7795096
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of fleroxacin (RO 23-6240) as single-oral-dose therapy of culture-proven chancroid in Nairobi, Kenya.
MacDonald KS; Cameron DW; D'Costa L; Ndinya-Achola JO; Plummer FA; Ronald AR
Antimicrob Agents Chemother; 1989 May; 33(5):612-4. PubMed ID: 2502065
[TBL] [Abstract][Full Text] [Related]
11. Correlation between in vitro antimicrobial susceptibilities and beta-lactamase plasmid contents of isolates of Haemophilus ducreyi from the United States.
Motley M; Sarafian SK; Knapp JS; Zaidi AA; Schmid G
Antimicrob Agents Chemother; 1992 Aug; 36(8):1639-43. PubMed ID: 1416845
[TBL] [Abstract][Full Text] [Related]
12. Single-dose therapy of chancroid with trimethoprim-sulfametrole.
Plummer FA; Nsanze H; D'Costa LJ; Karasira P; Maclean IW; Ellison RH; Ronald AR
N Engl J Med; 1983 Jul; 309(2):67-71. PubMed ID: 6343878
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology of chancroid and Haemophilus ducreyi in Nairobi, Kenya.
Plummer FA; D'Costa LJ; Nsanze H; Dylewski J; Karasira P; Ronald AR
Lancet; 1983 Dec; 2(8362):1293-5. PubMed ID: 6139629
[TBL] [Abstract][Full Text] [Related]
14. Short-course and single-dose antimicrobial therapy for chancroid in Kenya: studies with rifampin alone and in combination with trimethoprim.
Plummer FA; Nsanze H; D'Costa LJ; Ndugga Maggwa AB; Girouard Y; Karasira P; Albritton WL; Ronald AR
Rev Infect Dis; 1983; 5 Suppl 3():S565-72. PubMed ID: 6635447
[TBL] [Abstract][Full Text] [Related]
15. Trimethoprim sulphamoxole in the treatment of chancroid. Comparison of two single dose treatment regimens with a five day regimen.
Dylewski J; Nsanze H; D'Costa L; Slaney L; Ronald A
J Antimicrob Chemother; 1985 Jul; 16(1):103-9. PubMed ID: 3876325
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial therapy of chancroid: effectiveness of erythromycin.
Plummer FA; D'Costa LJ; Nsanze H; Maclean IW; Karasira P; Piot P; Fast MV; Ronald AR
J Infect Dis; 1983 Oct; 148(4):726-31. PubMed ID: 6355314
[TBL] [Abstract][Full Text] [Related]
17. Thiamphenicol in the treatment of chancroid in men.
Latif AS; Crocchiolo PR; Lencioni R
Sex Transm Dis; 1984; 11(4 Suppl):454-5. PubMed ID: 6335300
[TBL] [Abstract][Full Text] [Related]
18. Drug resistance of Haemophilus ducreyi.
Rutanarugsa A; Vorachit M; Polnikorn N; Jayanetra P
Southeast Asian J Trop Med Public Health; 1990 Jun; 21(2):185-93. PubMed ID: 2237585
[TBL] [Abstract][Full Text] [Related]
19. Susceptibility of Haemophilus ducreyi to spectinomycin in vitro.
Hafiz S; Jones BM; Kinghorn GR; Duerden BI
Genitourin Med; 1986 Aug; 62(4):251-2. PubMed ID: 2942458
[TBL] [Abstract][Full Text] [Related]
20. Chancroid in Sheffield. A report of 22 cases diagnosed by isolating Haemophilus ducreyi in a modified medium.
Hafiz S; Kinghorn GR; McEntegart MG
Br J Vener Dis; 1981 Dec; 57(6):382-6. PubMed ID: 6976815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
